Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
NCT00195013Phase 3Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Dec 2003
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in peripheral neuropathy, sponsored by Weill Cornell Medicine. Started Dec 2003; status: completed.
02
Drugs
glutamine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT00195013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195013.